Jane Street’s Strongbridge Biopharma plc. SBBP Stock Holding History

Jane Street’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-121,202	Closed	-$247K	–	11272
2021 Q3	$247K	Buy	121,202 +38,331	+46%	+$89.2K	﹤0.01%	8531
2021 Q2	$246K	Buy	82,871 +71,848	+652%	+$190K	﹤0.01%	8495
2021 Q1	$30K	Buy	+11,023	New	+$33.3K	﹤0.01%	8934
2020 Q4	–	Sell	-20,792	Closed	-$44K	–	8413
2020 Q3	$44K	Buy	+20,792	New	+$70.1K	﹤0.01%	6935
2019 Q3	–	Sell	-82,040	Closed	-$257K	–	6028
2019 Q2	$257K	Buy	+82,040	New	+$301K	﹤0.01%	4407
2018 Q3	–	Sell	-25,684	Closed	-$154K	–	5940
2018 Q2	$154K	Buy	+25,684	New	+$188K	﹤0.01%	4649

Jane Street's SBBP Position: Q4 2021 in Review

Jane Street sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 121,202 shares — an estimated $247K sold.

Jane Street first reported a position in SBBP in Q2 2018 and held it in 6 quarters. The position peaked at $257K in Q2 2019. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

Jane Street reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
Jane Street sold 121,202 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $247K.
Jane Street first reported a position in Strongbridge Biopharma plc. in Q2 2018 and held it in 6 quarters.
Jane Street's Strongbridge Biopharma plc. position peaked at $257K in Q2 2019.
0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on Jane Street's 13F filing for Q4 2021, filed 15 Feb 2022.